US Healthcare Professionals
Not an actual patient.
Enrolling your patients in the Rely On Redemplo Patient Support Program will introduce them to resources and services that can help support them throughout their treatment with Redemplo®.
Providers can begin enrolling appropriate patients by submitting a Redemplo Start Form, which captures all the information required to determine a patient’s insurance eligibility for Redemplo.
Providers can choose to prescribe Redemplo and help their patients enroll in the program directly online or via fax:
Questions? Contact a Redemplo Care Coordinator at 1-844-REDEMPLO (1-844-733-3675), Monday to Friday, 8 AM to 8 PM ET
Redemplo Care Coordinators are ready to assist with fulfilling prescriptions and supporting patients as they start on therapy.
Your Redemplo Reimbursement Navigator can also assist with questions. Call 1-844-REDEMPLO (1-844-733-3675), Monday to Friday, 8 AM to 8 PM ET.
REDEMPLO® (plozasiran) is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
CONTRAINDICATIONS: None.
ADVERSE REACTIONS: Most common adverse reactions in REDEMPLO treated patients (incidence ≥10% of patients treated with REDEMPLO and > 5% more frequently than with placebo) are hyperglycemia, headache, nausea, and injection site reaction.
Please see full Prescribing Information for REDEMPLO.